Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy-Reference-Cited by-同舟云学术

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Published:2020-09-01 Issue:9 Volume:138 Page:935
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Lim Tock H.¹²,Lai Timothy Y. Y.³,Takahashi Kanji⁴,Wong Tien Y.⁵,Chen Lee-Jen⁶,Ruamviboonsuk Paisan⁷,Tan Colin S.¹²,Lee Won Ki⁸,Cheung Chui Ming Gemmy⁵,Ngah Nor Fariza⁹,Patalauskaite Ramune¹⁰,Margaron Philippe¹¹,Koh Adrian¹²,

Affiliation:

1. National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore

2. Fundus Image Reading Centre, National Healthcare Group Eye Institute, Singapore

3. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China

4. Department of Ophthalmology, Kansai Medical University, Osaka, Japan

5. Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore, Singapore

6. Department of Ophthalmology, Mackay Memorial Hospital, Taipei, Taiwan

7. Department of Ophthalmology, Rajavithi Hospital, Bangkok, Thailand

8. Department of Ophthalmology, Seoul St Mary’s Hospital, The Catholic University of Korea, Seoul, Korea

9. Department of Ophthalmology, Hospital Shah Alam, Malaysia

10. Novartis Ireland Ltd, Dublin, Ireland

11. Novartis Pharma AG, Basel, Switzerland

12. Eye & Retina Surgeons, Camden Medical Centre, Singapore

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2768203/jamaophthalmology_lim_2020_oi_200052_1599662691.64104.pdf

Reference28 articles.

1. Polypoidal choroidal vasculopathy: an update on therapeutic approaches.;Wong;J Ophthalmic Vis Res,2013

2. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?;Laude;Prog Retin Eye Res,2010

3. Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management.;Cheung;Ophthalmology,2018

4. Polypoidal choroidal vasculopathy: clinical features and genetic predisposition.;Honda;Ophthalmologica,2014

5. Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography.;Iida;Br J Ophthalmol,2007

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the EVEREST II Study;Ophthalmology and Therapy;2024-02-03

2. Photodynamic Therapy for Eye, Ear, Laryngeal Area, and Nasal and Oral Cavity Diseases: A Review;Cancers;2024-02-02

3. Emerging Importance of Polypoidal Choroidal Vasculopathy;Ophthalmology Retina;2024-02

4. Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-01-31

5. A study of the relationship between cytokine levels and the response to anti-VEGF therapy in polypoid choroidal vasculopathy with different choroidal thicknesses;Frontiers in Endocrinology;2024-01-03